| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Medi Assist Healthcare Services Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-current assets |
|
|
|
Property, plant and equipment |
320.49 |
306.00 |
|
Right-of-use assets |
519.60 |
240.74 |
|
Goodwill |
1,299.30 |
1,291.78 |
|
Other intangible assets |
921.71 |
626.27 |
|
Intangible assets under development |
38.66 |
30.05 |
|
Investments |
30.44 |
78.72 |
|
Other financial assets |
226.55 |
166.32 |
|
Income tax assets (net) |
530.51 |
812.17 |
|
Deferred tax assets (net) |
136.57 |
140.87 |
|
Other non-current assets |
44.66 |
36.15 |
|
Current assets |
|
|
|
Investments |
2,710.47 |
689.59 |
|
Trade receivables |
2,213.58 |
1,786.25 |
|
Cash and cash equivalents |
830.14 |
509.27 |
|
Bank balances other than above |
1,020.46 |
1,129.80 |
|
Other financial assets |
425.15 |
336.57 |
|
Other current assets |
313.98 |
325.29 |
|
Total assets |
11,582.27 |
8,505.84 |
|
Equity and Liabilities |
|
|
|
Equity share capital |
352.61 |
351.05 |
|
Other equity |
5,062.09 |
4,366.37 |
|
Non-controlling interests |
106.87 |
95.92 |
|
Non-current liabilities |
|
|
|
Borrowings |
133.24 |
– |
|
Lease liabilities |
427.05 |
152.66 |
|
Other financial liabilities |
221.28 |
79.71 |
|
Provisions |
230.82 |
179.81 |
|
Deferred tax liabilities (net) |
5.72 |
85.75 |
|
Current liabilities |
|
|
|
Borrowings |
1,367.53 |
– |
|
Lease liabilities |
109.12 |
110.65 |
|
Trade payables (micro/small) |
79.68 |
30.28 |
|
Trade payables (others) |
227.82 |
395.75 |
|
Other financial liabilities |
628.94 |
186.67 |
|
Contract liabilities |
2,379.83 |
2,200.96 |
|
Other current liabilities |
103.61 |
135.30 |
|
Provisions |
129.46 |
119.00 |
|
Current tax liabilities (net) |
16.60 |
15.96 |
|
Total equity and liabilities |
11,582.27 |
8,505.84 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Income |
|
|
|
Revenue from operations |
7,233.21 |
6,347.25 |
|
Other income |
237.57 |
183.23 |
|
Total income |
7,470.78 |
6,530.48 |
|
Expenses |
|
|
|
Employee benefits expense |
3,058.63 |
2,545.28 |
|
Finance costs |
102.99 |
31.66 |
|
Depreciation and Amortisation |
557.82 |
430.77 |
|
Other expenses |
2,633.47 |
2,468.90 |
|
Total expenses |
6,352.91 |
5,476.61 |
|
Profit before tax (before exceptional) |
1,117.87 |
1,053.87 |
|
Exceptional item |
- |
210.00 |
|
Profit before tax |
1,117.87 |
843.87 |
|
Current tax
|
272.63 |
253.70 |
|
Adjustment for current tax relating to
earlier years |
(5.66) |
(48.76) |
|
Deferred tax (credit) |
(65.11) |
(74.02) |
|
Profit from continuing operations |
916.01 |
712.95 |
|
Discontinued operations
|
|
|
|
Profit/ (loss) before tax for the period/
year from discontinued operations |
(0.83) |
(27.49) |
|
Tax credit for the period/ year of
discontinued operations |
- |
6.36 |
|
Profit/ (loss) for the period/ year from discontinued
operations |
(0.83) |
(21.13) |
|
Profit for the period/ year |
915.18 |
691.82 |
|
Other comprehensive (loss)/ income |
|
|
|
Items that will not be reclassified
subsequently to profit or loss: |
|
|
|
Re-measurement of losses on defined benefit
plans |
(36.30) |
(8.94) |
|
Fair value changes in equity instruments
through other comprehensive income |
(8.39) |
15.60 |
|
Income tax relating to items that will not
be reclassified to profit or loss |
10.96 |
0.13 |
|
Item that will be reclassified to profit
and loss in subsequent periods: |
|
|
|
Exchange differences on translation of
foreign operations |
11.39 |
7.19 |
|
Total other comprehensive (loss)/ income for the
period/ year, net of tax |
(22.34) |
13.98 |
|
Total comprehensive income for the period/
year |
892.84 |
705.80 |
|
Profit for the period/ year attributable
to: |
|
|
|
Owners of the Company |
908.79 |
669.39 |
|
Non-controlling interest |
6.39 |
22.43 |
|
Other comprehensive (loss)/ income for the
period/ year attributable to: |
|
|
|
Owners of the Company |
(26.90) |
11.10 |
|
Non-controlling interest |
4.56 |
2.88 |
|
Total comprehensive income for the period/ year
attributable to: |
|
|
|
Owners of the Company |
881.89 |
680.49 |
|
Non-controlling interest |
10.95 |
25.31 |
|
Paid up equity share capital |
352.61 |
351.05 |
|
Other equity |
5062.09 |
4366.37 |
|
Earnings per equity share |
|
|
|
Basic (Rs) - from continuing operations |
12.92 |
10.02 |
|
Diluted (Rs) - from continuing operations |
12.86 |
9.84 |
|
Earnings/(loss) per equity share |
|
|
|
Basic (Rs) - from discontinued operations |
(0.01) |
(0.31) |
|
Diluted (Rs) - from discontinued operations |
(0.01) |
(0.31) |
|
Earnings per equity share |
|
|
|
Basic (Rs) |
12.91 |
9.71 |
|
Diluted (Rs) |
12.85 |
9.53 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash flows from operating activities |
|
|
|
Profit before tax (continuing) |
1,117.87 |
843.87 |
|
Loss before tax (discontinued) |
(0.83) |
(27.49) |
|
Adjustments for: |
|
|
|
Depreciation & Amortization |
557.82 |
430.77 |
|
Expected Credit Loss on trade receivables |
49.29 |
18.91 |
|
Doubtful advances/receivables |
18.48 |
7.69 |
|
Creditors/provisions written back |
(7.70) |
(37.02) |
|
Lease modification gain |
(1.43) |
(3.56) |
|
ESOP expense |
15.53 |
38.44 |
|
Finance costs |
102.99 |
31.66 |
|
Mutual fund gain |
(38.13) |
(14.27) |
|
Write-off of assets |
2.64 |
– |
|
Interest income |
(120.80) |
(108.28) |
|
FVTPL gain on financial assets |
(57.97) |
(8.12) |
|
Employee incentive plan |
– |
210.00 |
|
Forex differences (unrealised) |
2.55 |
0.90 |
|
Operating profit before WC changes |
1,640.31 |
1,383.50 |
|
Increase/(Decrease) Trade payables |
(108.40) |
88.24 |
|
Increase/(Decrease) Other liabilities |
421.06 |
(62.72) |
|
Increase/(Decrease) Provisions |
25.17 |
(42.59) |
|
Increase/(Decrease) Trade receivables |
(476.62) |
(411.17) |
|
Increase/(Decrease) Other assets |
(135.72) |
(19.49) |
|
Cash generated from operations |
1,365.80 |
935.77 |
|
Income tax paid (net) |
15.06 |
(271.94) |
|
Cash flows from investing activities |
|
|
|
Capex incl. intangibles |
(457.93) |
(184.24) |
|
Sale of non-current investments |
38.53 |
– |
|
Acquisition of subsidiaries |
– |
(1,087.25) |
|
Purchase of asset |
- |
(5.58) |
|
Sale of assets/business |
– |
6.41 |
|
Mutual fund (net) |
(1,924.78) |
(239.89) |
|
Bank deposits redemption |
26.13 |
860.64 |
|
Interest received |
135.61 |
101.27 |
|
Net cash (used in) investing |
(2,182.44) |
(548.64) |
|
Cash flows from financing activities |
|
|
|
Short-term borrowings (net) |
1,500.77 |
(0.77) |
|
Proceeds from ESOPs |
81.21 |
152.53 |
|
Lease liabilities paid |
(152.94) |
(162.13) |
|
Dividend paid |
(281.35) |
(130.14) |
|
Finance costs paid |
(26.97) |
(7.06) |
|
Net cash from financing activities |
1,120.72 |
(147.57) |
|
Net increase in cash |
319.14 |
(32.38) |
|
Opening cash |
509.27 |
539.44 |
|
Effect of exchange rate changes |
1.73 |
2.21 |
|
Total cash and cash equivalents at the end
of the year |
830.14 |
509.27 |
Here is a summary
of the Cash Flow Statement for the years 2025 and 2024:
Cash Flow from
Operating Activities
In FY
2025, Medi Assist reported a strong profit before tax
of Rs. 1,117.87 million from continuing operations, with a
small loss
from discontinued operations (Rs. 0.83 million). The profit was
significantly supported by non-cash adjustments including depreciation
and amortization of Rs. 557.82 million, expected credit
losses, finance costs, and doubtful
receivables, offset partially by gains from mutual
funds and fair value through profit or loss (FVTPL) investments
and interest
income. The total operating profit before working
capital (WC) changes stood at Rs. 1,640.31
million, showing a solid core operation.
Changes in working
capital showed mixed effects: a decrease in trade receivables (Rs.
476.62 million) and increase in other assets (Rs. 135.72
million) were cash outflows, while there was a notable
increase in other liabilities (Rs. 421.06 million). After
adjusting for these, the company generated Rs. 1,365.80
million in cash from operations, a significant improvement over
the previous year. Notably, Rs. 15.06 million in net income tax
refund contributed positively. Thus, FY 2025 ended
with a strong net cash inflow from operating activities.
In FY
2024, while the operating profit before WC changes
was Rs. 1,383.50 million, substantial increases in trade
receivables and declines in provisions and other liabilities reduced overall
cash generation. After adjusting for income taxes paid (Rs. 271.94 million),
the net
operating cash was Rs. 935.77 million, lower than FY 2025 but
still indicative of healthy operations.
Cash Flow from
Investing Activities
The company was aggressively
investing in FY 2025. It spent Rs. 457.93
million on capital expenditure (including intangible assets)
and Rs.
1,924.78 million on net mutual fund investments, which were
major cash outflows. Minor inflows included Rs. 38.53 million
from sale of non-current investments and Rs.
135.61 million as interest income. There were no
acquisitions or asset sales in FY 2025. Overall, this led to a significant
net cash outflow of Rs. 2,182.44 million from investing activities.
In contrast, FY
2024 saw a much lower net investment outflow of Rs. 548.64 million,
despite a large Rs. 1,087.25 million outlay for subsidiary acquisition.
This was balanced by a Rs. 860.64 million redemption of bank
deposits, making FY 2024’s investing cash flow less negative
than FY 2025.
Cash Flow from
Financing Activities
To support its
investment activities, Medi Assist raised significant capital in FY
2025, most notably Rs. 1,500.77 million from short-term
borrowings. The company also generated Rs. 81.21 million
from ESOP proceeds, though it paid out Rs. 281.35
million in dividends, Rs. 152.94 million towards lease
liabilities, and Rs. 26.97 million in finance costs.
Despite these outflows, the company had a net financing
inflow of Rs. 1,120.72 million.
In FY
2024, financing activities resulted in a net
outflow of Rs. 147.57 million, due to lower borrowing activity
and similar levels of dividend and lease payments.
Net Cash
Movement and Closing Position
For FY
2025, the company’s net cash inflow stood at Rs. 319.14
million, reflecting strong operating cash flow and successful
financing, despite heavy investing. With an opening cash
balance of Rs. 509.27 million and a minor positive
forex adjustment of Rs. 1.73 million, the company ended the
year with Rs.
830.14 million in cash and cash equivalents.
